Magic mushroom compound takes on tough depression in major trial
NCT ID NCT05624268
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This phase 3 trial tests whether a single dose of COMP360 psilocybin, given under supportive conditions, can safely reduce depression symptoms in 255 adults with treatment-resistant depression. Participants are randomly assigned to receive either the drug or a placebo, and their mood and daily functioning are tracked over time. The study aims to see if this psychedelic-assisted approach offers relief where standard treatments have failed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- psilocybin (COMP360)
- What this could lead to
- If it works, this could offer a new, fast-acting option for people with depression that hasn't responded to other treatments.
- What could go wrong
- This is a single-dose study, and long-term effects are unknown. The psychedelic experience may cause temporary distress, and not everyone may benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APG Research, LLC
Orlando, Florida, 32803, United States
-
ASCLEPES Research Centers
Thousand Oaks, California, 93012, United States
-
ATP Clinical Research, Inc.
Orange, California, 92868, United States
-
Alivation Research, LLC.
Lincoln, Nebraska, 68526, United States
-
Artemis Institute for Clinical Research
San Diego, California, 92103, United States
-
Bio Behavioral Health
Toms River, New Jersey, 08755, United States
-
CBH Health, LLC
Gaithersburg, Maryland, 20877, United States
-
CalNeuro Research Group, Inc
Los Angeles, California, 90025, United States
-
California Center for Psychedelic Therapy
Los Angeles, California, 90004, United States
-
Cedar Clinical Research
Draper, Utah, 84020, United States
-
Clarity Clinical Research, LLC
Los Angeles, California, 90064, United States
-
Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare
Orlando, Florida, 32801, United States
-
Collaborative Neuroscience Network, LLC
Garden Grove, California, 92845, United States
-
Comprehensive Psychiatric Care
Norwich, Connecticut, 06360, United States
-
Core Clinical Research
Everett, Washington, 98201, United States
-
DMI Health Care Group, Inc
Tampa, Florida, 33782, United States
-
Emory University
Atlanta, Georgia, 30329-2209, United States
-
Global Medical Institutes, LLC, Scranton Medical Institute
Moosic, Pennsylvania, 18507, United States
-
Insight Clinical Trials, LLC
Beachwood, Ohio, 44122, United States
-
Kadima Neuropsychiatry Institute
La Jolla, California, 92037, United States
-
Lumos Clinical Research Center
San Jose, California, 95124, United States
-
Meridien Research/Accel Research
Tampa, Florida, 33803, United States
-
Midwest Research Group
Saint Charles, Missouri, 63304, United States
-
Neuro-Behaviroral Clinical Research, Inc.
North Canton, Ohio, 44720, United States
-
New York State Psychiatric Institute
New York, New York, 10032, United States
-
Pharmasite Research, Inc
Pikesville, Maryland, 21208, United States
-
ProScience Research Group
Culver City, California, 90230, United States
-
Psych Atlanta
Atlanta, Georgia, 30060, United States
-
Rivus Wellness & Research Institute
Oklahoma City, Oklahoma, 73112, United States
-
Sheppard Pratt Health System
Baltimore, Maryland, 21044, United States
-
Stanford University
Stanford, California, 94305, United States
-
The Medical Research Network, LLC
New York, New York, 10128, United States
-
UT Health Science Center at Houston (UTHSC-H)
Houston, Texas, 77030, United States
-
University California San Diego
La Jolla, California, 92037, United States
-
University of Arizona College of Medicine - Tuscon
Tuscon, Arizona, 85724, United States
-
University of Massachusetts Medical School
North Worcester, Massachusetts, 01655, United States
-
University of Minnesota
Minneapolis, Minnesota, 55416, United States
-
University of Missouri
Columbia, Missouri, 65212, United States
-
Uptown Research Institute, LLC
Chicago, Illinois, 60640, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain 'Radio' tunes into Depression's neural signals
- Magic mushroom compound tested for dual relief of chronic pain and depression
- Ketamine plus talk therapy shows promise for stubborn depression
- Brain zaps guided by scans: a new hope for untreatable depression?
- Magic mushroom compound may offer new hope for stubborn depression
- Can a blood test predict who will respond to ketamine for depression?